Abstract. Ultrasound cavitation of microbubble contrast agents has a potential for therapeutic applications, including sonothrombolysis in acute ischemic stroke. For safety, efficacy, and reproducibility of treatment, it is critical to evaluate the cavitation state (e.g. stable versus inertial forms of cavitation) and intensity in and around a treatment area. Acoustic Passive Cavitation Detectors (PCDs) have been used but do not provide spatial information. This paper presents a prototype of a 2D cavitation imager capable of producing images of the dominant cavitation state and intensity in a region of interest at a frame rate of 0.6Hz. The system is based on a modified ultrasound scanner (iE33, Philips) with a sector imaging probe (S5-1). Cavitation imaging is based on the spectral analysis of the acoustic signal radiated by the cavitating microbubbles: ultraharmonics of the excitation frequency indicate stable cavitation, while noise bands indicate inertial cavitation. The system demonstrates the capability to robustly identify stable and inertial cavitation thresholds of Definity microbubbles (Lantheus) in a vessel phantom through 3 ex-vivo human temporal bones, as well as to spatially map cavitation activities.
INTRODUCTION
Therapeutic uses of microbubble (MB) ultrasound (US) contrast agents are emerging, notably for drug and gene delivery [1] and sonothrombolysis [2] . In the context of stroke, the addition of US and MBs to standard tPA thombolytic therapy has been shown to accelerate thrombus dissolution in humans [3] . However, MB cavitation also has the potential for detrimental side effects under certain circumstances. Tung et al. [4] have observed Blood-Brain-Barrier (BBB) opening in mice with acoustic Peak Negative Pressures (PNPs) as low as 0.3MPa; red blood cell extravasations were documented at 0.6MPa. Although these bioeffects are probably benign by themselves, they may become dangerous in the presence of the anticoagulant and neurotoxic drug, tPA. There is some evidence in humans that, when cavitation is seeded by MBs and tPA is present, even relatively low PNPs (<0.3MPa) can increase the rate of symptomatic hemorrhage [5] . US and MBs alone (without tPA) have thrombolytic effects as demonstrated in animal studies [6] [7] [8] and a limited number of human subjects [9] , but this may require higher acoustic pressures for optimal efficacy [6] [7] [8] . Because human skulls exhibit a wide range of acoustic attenuations from patient to patient [10] , it is essential to control the acoustic intensity and type of MB cavitation that is generated inside a treatment area for both safety and efficacy of treatment. Single-element Passive Cavitation Detectors (PCDs) have been used for this purpose [11] but they do not provide information on the heterogeneous spatial distribution of cavitation activities.
This paper presents a prototype imaging system (based on a commercial ultrasound scanner) capable of producing images of the dominant cavitation state and intensity in a region of interest at a frame rate of 0.6Hz. Such a tool will be useful in advancing the understanding of cavitation mechanisms in sonothrombolysis and other US+MB-enabled therapies, as well as allow safe and effective sonothrombolysis treatment with or without tPA.
METHODS
Experimental setup: The experimental setup for testing the cavitation imager is depicted in Fig. 1 (left) . Definity MBs at an approximate concentration of 0.01mL/L (Lantheus medical imaging, N. Billerica, MA) are circulated in closed-loop inside a 4mm-diameter vessel phantom (model 524, ATS laboratories, Bridgeport, CT) using 13mm-diameter tubing and a peristaltic pump set at 125mL/min (Masterflex Digistaltic model 77200-60, Cole-Parmer, Vernon Hills, IL). The phantom is imaged and insonified longitudinally with a 2D imaging array (see below: 'acoustic conditions'). Three ex vivo human temporal bone samples with no trabecular bone are embedded in gelatin and can be inserted between the imaging probe and the phantom. o Two 1.7µs pulses (used to generate a background echo image) are interleaved between consecutive ensembles of 4. o Additional 1.7µs 'echo' pulses are sent into a ~90° sector.
-The pulse repetition frequency (PRF) is ~8kHz and the frame rate is ~10Hz.
-The active aperture of the S5-1 probe is ~2x1cm 2 , with a ~6cm transmit focus. PNP calibration: The output amplitude of the ultrasound system is controlled in 0.5dB increments of the driving voltage. In a separate calibration experiment, hydrophone measurements (Ø 0.2mm, Precision Acoustic LTD, United Kingdom) of the peak negative pressure were performed at increasing driving voltages of the sonothrombolysis pulses. A 5cm-thick tissue mimicking phantom (TMP) with a nominal attenuation of 0.49dB/MHz/cm was inserted between the S5-1 probe and the hydrophone. Efforts were made to place the hydrophone at the spatial peak of PNP. These measurements are used throughout the paper to document 'nominally derated' PNPs.
Cavitation imaging algorithm: The frame rate of the system is decreased to 0.6Hz. The radiofrequency (RF) data corresponding to acoustic backscatter/re-radiation by the insonified medium toward the imaging probe is recorded and streamed to a separate workstation where it is analyzed in Matlab (The Mathworks, Natick, MA).
i. Two consecutive pulses within each ensemble of 4 are subtracted from each other to suppress stationary 'tissue' signal.
ii. Five temporal filters are applied to the resulting RF signals: a. bandpass at the harmonic frequency (2f 0 ), b. bandpass at the ultraharmonic frequency (1.5f 0 ), c. bandpass at intermediate 'noise' frequencies (1.25f 0 and 1.75f 0 ), d. high-pass excluding the fundamental frequency (1.25f 0 and up). The filter bandwidths are matched to the sonothrombolysis pulse bandwidths. The ultraharmonic filter is a proxy for Stable Cavitation (SC) strength, the noise filters are proxies for Inertial Cavitation (IC) strength, and the high-pass filter is a proxy for overall cavitation strength [11] .
iii. The filtered data are envelope-detected. Four images are formed based on the 5 sets of temporally filtered and envelope-detected data: a. an SC image corresponds to the ultraharmonic-filtered data; b. an IC image corresponds to the average of the two noise band-filtered data, c. a 'bubble activity' image corresponds to the high-passfiltered data, d. a 'harmonic' image corresponds to the harmonic-filtered data. These images are then log-compressed and scan-converted.
iv. These four images are used to form one composite cavitation image. The brightness of a given pixel is that of the 'bubble activity' image. If this value is under a threshold, the background echo image is displayed in gray-scale. A color-coding scheme is applied as follows: a. if the SC value is greater than the IC value by a threshold (e.g. 5dB), this indicates dominant SC and the corresponding pixel is colored in yellow; b. if this does not apply and the IC value is greater than a certain fraction of the 'harmonic' value (e.g. -10dB), this indicates strong IC and the corresponding pixel is colored in red; c. if neither a nor b apply, there is no dominant SC or IC and the corresponding pixel is colored in green.
v. 'Instantaneous cavitations doses' are estimated as spatial averages across the entire image for one frame: the SC is the spatial average of the SC image, the IC dose' is the spatial average of the IC image.
EXPERIMENTAL RESULTS
Cavitation imaging: Sample cavitation images of the vessel phantom, through a water path and through one ex vivo temporal bone are presented in Fig. 2 . A pulse length of 20µs is used. As the acoustic pressure increases, the image brightness increases indicating stronger cavitation activity; the color of the vessel cycles from mostly green (no strong SC or IC) to yellow (dominant SC) to red (dominant IC). The thresholds for dominant SC or IC occur at higher applied acoustic outputs through the skull sample than through the water paths, which is expected as the attenuation from the skull needs to be offset. A lateral gradient of cavitation activities and types can be observed with higher cavitation states and intensities at the center of the image; this can be explained by cosine decrease in power as a function of steering angle from a phased array; this effect is exacerbated through the skull due to the angle-dependent ultrasound attenuation through bone [12] . Dose monitoring: The 'instantaneous doses' of both SC and IC are monitored while increasing the acoustic output from the scanner. Three measurements are recorded at each acoustic output to produce mean standard deviation values. Cavitation doses curves through a water path using different acoustic pulse lengths (10, 20 and 44µs) are shown in Fig. 3 . The experiment with the 20µs pulse length was repeated with an approximate doubling of the microbubble concentration to investigate a possible effect of the microbubble concentration on the shape of the cavitation dose curves.
Skull attenuation: The skull exhibits frequency-dependent attenuation potentially compromising the sensitivity of this cavitation monitoring technique that is based on spectral analysis. The aim of this experiment was to see if the thresholds for stable and inertial cavitation could still be clearly identified through the skull samples. Cavitation dose curves are obtained through 3 ex vivo human temporal bone samples. SC and IC thresholds can be distinguished with robustness in all cases (Fig. 4) (the threshold is the 'derated PNP' value when a curve reaches 1/20 th of its maximum). These thresholds occur at higher applied acoustic outputs because skull attenuation must be overcome. Table I summarizes the measured thresholds through water and through the skulls, as well as an estimate of each skull's attenuation based on the measurements and a hypothesis of a linear relationship between attenuation and PNP. 
CONCLUSIONS AND DISCUSSION
An imaging transducer can be used to deliver sonothrombolysis pulses and monitor the dominant state and intensity of cavitation activities present in a treatment area. Such a tool will be useful in advancing the understanding of cavitation mechanisms in sonothrombolysis and other US+MB-enabled therapies, as well as allow safe and effective sonothrombolysis treatment with or without tPA. Cavitation imaging enables treatment planning (estimating skull attenuation and compensating for it by adjusting the output power) and monitoring (generating and updating 2D cavitation doses maps). Current technical limitations of the technique include:
-Limited axial resolution (determined by the pulse length, it corresponds to 1.5cm at 20µs). Shorter pulses yield better resolution but less robust cavitation states and poorer spectral resolution; -The 'tissue suppression' step involving subtraction of two consecutive pulses is necessary to eliminate tissue interferences but results in non-linear dose estimates. The cavitation 'doses' as measured by this technique is thus only qualitative;
Further work will include in vivo evaluation of the robustness of the technique: it is known that bubble behavior depends on the size and compliance of vessels, the perfusion/flow rate, and other physiological parameters. Different bubble formulations that may yield different spectral responses will also be evaluated.
